Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rhinitis | 10 | 2025 | 169 | 3.480 |
Why?
|
| Sinusitis | 10 | 2025 | 227 | 3.300 |
Why?
|
| Paranasal Sinuses | 4 | 2024 | 81 | 2.280 |
Why?
|
| Endoscopy | 5 | 2024 | 317 | 1.410 |
Why?
|
| Eosinophil Peroxidase | 2 | 2024 | 9 | 1.040 |
Why?
|
| Rhinitis, Allergic | 1 | 2025 | 42 | 0.850 |
Why?
|
| Environmental Exposure | 2 | 2025 | 578 | 0.780 |
Why?
|
| Otolaryngologists | 1 | 2023 | 13 | 0.770 |
Why?
|
| Osteitis | 1 | 2022 | 5 | 0.750 |
Why?
|
| Environmental Monitoring | 1 | 2025 | 347 | 0.730 |
Why?
|
| Air Pollution | 1 | 2025 | 315 | 0.670 |
Why?
|
| Air Pollutants | 1 | 2025 | 407 | 0.640 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 2770 | 0.630 |
Why?
|
| Nasal Cavity | 1 | 2019 | 61 | 0.590 |
Why?
|
| Algorithms | 2 | 2024 | 1851 | 0.580 |
Why?
|
| Neck Dissection | 1 | 2018 | 17 | 0.580 |
Why?
|
| Specimen Handling | 1 | 2019 | 183 | 0.540 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 90 | 0.540 |
Why?
|
| Chronic Disease | 7 | 2025 | 1812 | 0.520 |
Why?
|
| Tampons, Surgical | 1 | 2017 | 1 | 0.510 |
Why?
|
| Epistaxis | 1 | 2017 | 17 | 0.510 |
Why?
|
| Elective Surgical Procedures | 1 | 2018 | 203 | 0.510 |
Why?
|
| Frontal Sinus | 1 | 2016 | 6 | 0.500 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 52 | 0.480 |
Why?
|
| Rhinoplasty | 1 | 2016 | 39 | 0.470 |
Why?
|
| Skull | 1 | 2016 | 163 | 0.450 |
Why?
|
| Biocompatible Materials | 2 | 2017 | 429 | 0.440 |
Why?
|
| Fibrosarcoma | 1 | 2014 | 23 | 0.430 |
Why?
|
| Tracheal Neoplasms | 1 | 2014 | 12 | 0.430 |
Why?
|
| Tracheal Stenosis | 1 | 2014 | 39 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 641 | 0.400 |
Why?
|
| Airway Obstruction | 1 | 2014 | 153 | 0.370 |
Why?
|
| Postoperative Complications | 4 | 2024 | 2977 | 0.360 |
Why?
|
| Disease Progression | 3 | 2024 | 2865 | 0.210 |
Why?
|
| Humans | 17 | 2025 | 145785 | 0.200 |
Why?
|
| Aged | 6 | 2024 | 26217 | 0.200 |
Why?
|
| Wound Healing | 2 | 2017 | 355 | 0.200 |
Why?
|
| Smell | 1 | 2024 | 126 | 0.190 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1475 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2018 | 1752 | 0.170 |
Why?
|
| Particulate Matter | 1 | 2024 | 326 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 40882 | 0.160 |
Why?
|
| Middle Aged | 6 | 2024 | 36309 | 0.160 |
Why?
|
| Nasal Lavage Fluid | 1 | 2019 | 15 | 0.150 |
Why?
|
| Cytological Techniques | 1 | 2019 | 27 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 381 | 0.150 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 112 | 0.140 |
Why?
|
| Exosomes | 1 | 2019 | 104 | 0.140 |
Why?
|
| Neck | 1 | 2018 | 109 | 0.140 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 336 | 0.130 |
Why?
|
| Female | 8 | 2024 | 79045 | 0.130 |
Why?
|
| Patient Comfort | 1 | 2017 | 12 | 0.130 |
Why?
|
| Ultrasonic Waves | 1 | 2016 | 9 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 736 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2022 | 17330 | 0.120 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 6085 | 0.120 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2933 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2024 | 8078 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2018 | 509 | 0.120 |
Why?
|
| Male | 6 | 2024 | 73012 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2016 | 309 | 0.110 |
Why?
|
| Prognosis | 1 | 2024 | 4330 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 3418 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 199 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 185 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2014 | 305 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2014 | 116 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 1925 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 508 | 0.090 |
Why?
|
| Tracheostomy | 1 | 2014 | 142 | 0.090 |
Why?
|
| Biomarkers | 1 | 2024 | 4302 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 5428 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2016 | 1115 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 563 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2024 | 11794 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1723 | 0.080 |
Why?
|
| Peptides | 1 | 2016 | 1000 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2014 | 714 | 0.070 |
Why?
|
| United States | 1 | 2023 | 16126 | 0.060 |
Why?
|
| Tryptases | 1 | 2022 | 12 | 0.040 |
Why?
|
| Substance P | 1 | 2022 | 38 | 0.040 |
Why?
|
| Social Class | 1 | 2024 | 264 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2024 | 375 | 0.040 |
Why?
|
| Quality of Life | 2 | 2024 | 3211 | 0.040 |
Why?
|
| Young Adult | 1 | 2016 | 14254 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 373 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 36 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 65 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 25 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2022 | 789 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 86 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 91 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 162 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2016 | 122 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 249 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 193 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 4090 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2805 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 5226 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 38106 | 0.010 |
Why?
|